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In order to gain insight into the effects of human breast milk on the development of the intestinal
bifidobacteria and associated health effects, the transcriptome of Bifidobacterium longum LMG 13197 grown in
breast milk and formula milk containing galactooligosaccharides (GOS) and long-chain fructooligosaccha-
rides was compared to that obtained in a semisynthetic medium with glucose. Total RNA was isolated from
exponentially growing cells and hybridized to a clone library-based microarray. Inserts of clones with signif-
icant hybridization signals were sequenced and identified. The B. longum transcriptomes obtained during
growth on human and formula milk were more similar to each other than to that obtained from growth in
semisynthetic medium with glucose. Remarkably, there were only a few genes implicated in carbohydrate
metabolism that were similarly upregulated during growth in both human and formula milk although oligo-
saccharides were added to the formula. Common highly upregulated genes notably included putative genes for
cell surface type 2 glycoprotein-binding fimbriae that are implicated in attachment and colonization in the
intestine. Genes involved in carbohydrate metabolism formed the dominant group specifically upregulated in
breast milk and included putative genes for N-acetylglucosamine degradation and for metabolism of mucin and
human milk oligosaccharides via the galactose/lacto-N-biose gene cluster. This supports the notion that the
bifidogenic effect of human milk is to a great extent based on its oligosaccharides. The transcriptional effect of
semisynthetic medium containing GOS, which, like human milk, contains a large amount of lactose and
galactose, on the B. longum transcriptome was also studied and revealed substantial similarity with carbohy-
drate-utilization genes upregulated during growth in human milk. This knowledge provides leads to optimizing
formula milk to better simulate the observed bifidogenic effects of human breast milk.
The developing gut microbiota is profoundly influenced by
the feeding regimen of babies, and typically within a few days
of life, human milk stimulates bifidobacteria to become quite
dominant (1, 28). In breast-fed infants bifidobacteria have
been reported to reach up to 90% of the infant gut microbiota;
in contrast, formula-fed infants have a more complex micro-
biota (14). The postnatal maturation of a balanced immune
system requires constant microbial stimulation from the devel-
oping gut microbiota, and a high level of bifidobacteria has
been associated with reduced intestinal infections (10, 18).
Complex neutral oligosaccharides have been identified as the
most likely so-called prebiotic factors in human milk that stim-
ulate the growth of bifidobacteria in the infant gut (6, 11, 13).
After lactose and lipids, the oligosaccharides are quantitatively
the third components of human milk; they are only partially
digested in the small intestine, so they reach the colon, where
they selectively stimulate the development of microbiota dom-
inated by bifidobacteria (11). Oligosaccharides with structures
identical to human milk are not yet available as dietary ingre-
dients because of their complexity (6). The core molecule of
human milk oligosaccharides is characterized by repetitive at-
tachment of monosaccharide units (galactose, fucose, N-acetyl-
glucosamine, and sialic acid) to the basic molecule of lactose,
thus forming compounds with both linear and branched struc-
tures (11). Proteolytic fragments of major human milk proteins
were also shown to be effective as a growth factor for bi-
fidobacteria (25). Prebiotics are defined as nondigestible food
ingredients that beneficially affect the host by selectively stim-
ulating the growth and/or activity of one or a limited number of
bacteria in the colon and thus improve host health (15). Like
human milk oligosaccharides, the supplementation of infant
formula with certain prebiotics stimulates the number of fecal
bifidobacteria (2, 8, 11, 16, 36). Feeding infants formula sup-
plemented with galactooligosaccharides and long-chain fruc-
tooligosaccharides (GOS-lcFOS, 1:9) significantly increased
the number of bifidobacteria and was accompanied by a re-
duction of pathogens in both preterm infants and term infants
(7, 22, 23). Moreover, the GOS-lcFOS supplement caused the
microbial diversity to closely resemble the microbiota of
breast-fed infants, also at the level of the different Bifidobac-
terium species (2, 16). GOS are manufactured from lactose by
using the enzyme -galactosidase to attach glycosyl residues,
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which results in complex mixtures with various glycosidic link-
ages (12). Note that the core molecule in human milk is char-
acterized by repetitive attachment of galactose and N-acetyl-
glucosamine in -glycosidic linkage to lactose (8). GOS alone
have previously been demonstrated to be metabolized by bi-
fidobacteria in vitro (42) and to increase fecal bifidobacterial
numbers in vivo (27).
The molecular mechanisms that underlie the influence of
breast-feeding on the development of the intestinal bifidobac-
terial community are not yet completely understood. The pub-
lication of the genome sequence from Bifidobacterium longum
NCC2705 revealed that the chromosome encodes numerous
genes for carbohydrate utilization collectively termed the gly-
cobiome (38). Sequence data indicated a preference for di-,
tri-, and oligosaccharides, pointing toward a bias for complex
oligosaccharides (33, 34) complemented with transporters for a
variety of disaccharides and oligosaccharides (33). This sug-
gests adaptation to a special colonic niche and utilization of
specific dietary components (38). Recently, a bifidobacterium-
specific microarray platform comprising clone library-contain-
ing inserts of seven bifidobacterial species was constructed (9).
In the present study the effects of human milk and formula
milk on the global gene expression of B. longum were investi-
gated to gain some insight into the impact of the milks on the
development and colonization of intestinal bifidobacteria
within the infant gut. Transcriptomics was performed on B.
longum LMG 13197 during growth in human and formula milk
with GOS-lcFOS and in comparison to semisynthetic medium
with glucose. This was complemented with a study of the met-
abolic effect of semisynthetic medium with GOS on the B.
longum transcriptome.
MATERIALS AND METHODS
Bacterial strains and cultivation conditions. B. longum LMG 13197 was ob-
tained from the Laboratorium voor Microbiologie (LMG) collection (Ghent,
Belgium) and has been isolated from human infant feces. B. longum LMG 13197
was maintained in deMan-Rogosa-Sharpe (MRS) medium and glycerol (1:1,
vol/vol) at 80°C. An overnight culture (no more than 12 h old) grown in
Trypticase-peptone-yeast extract-glucose medium, pH 7 (5), was used as an
inoculum (5%, vol/vol) after two washing steps to remove residual medium.
Growth in milk and semisynthetic medium with prebiotics. Human milk was
aseptically collected from two volunteers with a sterile pump and immediately
frozen at 20°C. Written consent was received from all subjects who provided
human breast milk. Commercial formula milk (Nutrilon 1 with GOS and poly-
fructose; Nutricia, Zoetermeer, The Netherlands) was dissolved to 10% in demi-
neralized water. Both milks were centrifuged for 5 min at 5,000 rpm (4°C) and
filtered to remove fat. Filtered-sterilized cysteine was added (0.5 g/liter), and the
pH was adjusted to 6.5. Fifty milliliters of milk was added to sterile flasks with
stoppers; flasks were sealed with aluminum rings and placed in a water bath for
20 min at 80°C. After flasks were cooled to room temperature, they were flushed
with CO2/N2 using sterile filters. They were incubated a second time in a water
bath for 20 min at 80°C and cooled to room temperature overnight. A semisyn-
thetic medium was prepared with a minimal carbon source (6.7 g/liter yeast
nitrogen base [Difco]), 0.5 g/liter cysteine, 1 ml of Tween 80, and a 40% [vol/vol]
salt solution consisting of 0.2 g/liter CaCl2, 1 g/liter K2HPO4, 1 g/liter KH2PO4,
10 g/liter NaHCO3, 2 g/liter NaCl, 0.5 g/liter casein enzymatic hydrolysate, 0.05
g/liter sodium thioglycolate) such that it could be supplemented with the differ-
ent carbon sources to be monitored (19). Transcriptomics of B. longum in human
or formula milks were compared to the semisynthetic medium containing 5
g/liter glucose as a sole carbon source (hereafter, glucose medium). The number
of CFU was determined by plating on MRS agar medium (Difco, France) with
cysteine (0.5 g/liter), followed by incubation at 37°C anaerobically. The semisyn-
thetic medium supplemented with GOS (composed of 33% disaccharides, 39%
trisaccharides, 18% tetrasaccharides, 7% pentasaccharides, and 3% hexa-,
hepta-, and octasaccharides; Friesland Foods, The Netherlands) (hereafter, GOS
medium) as a sole carbon source was used to study the transcriptomics of B.
longum in prebiotics. For comparative purposes B. longum was grown in semi-
synthetic medium with glucose or no carbon source. Carbon solutions were
sterilized separately and added prior to fermentation at a final concentration of
5 g/liter. All media and carbon solutions were flushed with CO2/N2; flasks were
closed with rubber stoppers, sealed with aluminum rings, and sterilized at 120°C
for 15 min. Growth was followed by measuring the optical density at 600 nm
(OD600). All tests were performed in duplicate at 37°C with agitation (200 rpm)
for 10 h, and samples were taken every 2 h for pH measurements and determi-
nation of the number of CFU by plating on MRS medium with cysteine (0.5
g/liter), as described above.
RNA isolation and purification. Cells for RNA isolation (50 ml) were har-
vested at mid-exponential phase (pH 5; OD600 of 0.5) and concentrated imme-
diately by centrifugation at 12,000 rpm for 10 min at 4°C. After centrifugation,
the supernatant was discarded, and the cell pellet was snap frozen in liquid
nitrogen and stored at 80°C. Samples for RNA isolation were taken from milk
and glucose medium cultures after 4 h and from GOS cultures after 6 h (Fig. 1
and 2). RNA isolation was performed using the Macaloid clay method as pre-
viously described (35). Briefly, cell pellets were resuspended in 0.5 ml of Tris-
EDTA buffer (10 mM; pH 7.5) added to tubes containing 0.8 g of 0.1-mm
zirconia beads (Biospec Products, Bartlesville, OK), 0.18 g of Macaloid clay in
Tris-EDTA buffer (Kronos Titan GmbH, Leverkusen, Germany), 50 l of 10%
FIG. 1. Growth (log10 CFU/ml) (A) and pH curves (B) for B. longum in glucose medium (}), human breast milk (f), and formula milk (Œ).
An arrow indicates the harvest point for RNA isolation.
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sodium dodecyl sulfate (SDS), and 0.5 ml of acidic phenol (pH 3.75). Cells were
disrupted using three treatments of 45 s in a Fastprep (Qbiogene) interspersed
by a 90-s incubation on ice. After disruption the samples were centrifuged at 4°C
for 10 min at 12,000 rpm. The aqueous phase was used for RNA isolation by
extraction with chloroform-phenol-isoamylalcohol (1:1:1) twice and with chloro-
form-isoamylalcohol (1:24) once. This was followed by a cleaning step using
RNeasy columns (Qiagen Sciences, MD), according to the RNeasy cleaning
protocol, and treatment with DNase (Roche Diagnostics, Mannheim, Germany)
on the column. After elution from the column, RNA concentrations were mea-
sured using the Nanodrop ND-1000 (Nanodrop Technologies, Wilmington, DE).
Additionally, quality and concentration of the RNA were measured using an
Experion Automated Electrophoresis System (Bio-Rad) with RNA StdSens mi-
crofluidic chips. Total RNA samples with a 16S/23S rRNA ratio of at least 2.0
were used for microarray experiments.
Reverse transcription of RNA. Five micrograms of RNA was mixed with 2.5 l
of random p6 primer (2 g/l; Roche Diagnostics, Mannheim, Germany) and 2
U of RNasin (Promega, Madison, WI). This was incubated on ice for 10 min
following an incubation of 5 min at 70°C and cooled to room temperature. On
ice, 5 U of RNasin, 0.1 M dithiothreitol, aminoallyl-deoxynucleoside triphos-
phate, and 200 U of Superscript II RT enzyme (Life Technologies S.A., Merel-
beke, Belgium) were added and incubated for 3 h at 42°C. RNA was hydrolyzed
by adding 6.25 mol of NaOH and incubated at 37°C for 30 min. To neutralize
pH, 6.25 mol of acetate was added. Unincorporated aminoallyl-dUTP and free
amines were removed using QIAquick columns (Qiagen Sciences) according to
the supplier’s protocol.
Fluorescent labeling and hybridization to bifidobacterial microarrays. The
microarray slides were provided by TNO Nutrition and Food Research, The
Netherlands (9). The array contained 2,000 spots of a B. longum LMG 13197
clone library containing an average insert size of approximately 1.5 kb covering
85% of the genome. Slides were incubated in preheated prehybridization solu-
tion (1% bovine serum albumin, 5 SSC [1 SSC is 0.15 M NaCl plus 0.015 M
sodium citrate], 0.1% SDS; filtered by 0.45-m-pore-size filters) at 42°C for 45
min under rotation, washed, and dried under N2 flow. cDNA was dissolved in 4.5
l of 0.1 M sodium carbonate buffer, pH 9.0, for 10 min at room temperature. An
aliquot of 4.5 l of the appropriate N-hydroxysuccinimide ester Cy dye was
added and incubated in the dark at room temperature for 1 h. After incubation,
unincorporated dyes were removed using Autoseq G50 columns (Amersham-
Biosciences, Freiburg, Germany). The Cy5- and Cy3-labeled probes were com-
bined and dried using vacuum centrifugation. The samples were dissolved in 45
l of Easyhyb buffer at 42°C for 15 min. The preparations were mixed well and
spun down briefly. The subsequent steps were performed at 42°C. The prehy-
bridized microarray slides were placed on hybridization chambers (Corning)
moistened with MilliQ water. Hybridization mixtures were pipetted onto the
slides and covered with glass lids. The chambers were immediately sealed, and
the hybridization was then allowed to take place overnight at 42°C. Afterwards,
the slides were washed by placing them in 50-ml tubes containing the following
wash solutions at 37°C and agitated for 10 s: 1 SSC–0.2% SDS, 0.5 SSC, 0.2
SSC; finally the slides were washed twice in 0.2 SSC with agitation on a rotation
plateau for 10 min. The slides were dried under N2 flow and scanned using
ScanArray (Perkin Elmer) using two wavelengths corresponding to the excitation
wavelengths of the Cy3 and Cy5 dyes. Scanned images of the slides were further
processed with ImaGene, version 5.6, software.
Analysis of microarray data. The microarray experimental design for the
various samples is presented in Fig. 3. Samples for each condition were hybrid-
ized in duplicate. Human milk samples were compared to the formula milk and
to samples of semisynthetic medium with glucose, which were also compared to
GOS medium samples. For data analysis, flagged spots were eliminated, followed
by background subtraction, log transformation, and Lowess fit normalization,
using the Arraynorm program (http://genome.tugraz.at). Positive signals in bio-
logical replicates were analyzed for significant differential expression, using sig-
nificance analysis of microarray with the Tigr Multiarray viewer program (37).
Raw microarray data are available in the supplemental material.
Nucleotide sequencing and analysis. A selection of inserts was sequenced by
GATC Biotech (Germany). The Smith and Waterman algorithm (40) was ap-
plied to search the obtained sequences against the complete protein and nucle-
otide sequences of all completely sequenced genomes present in the NCBI repos-
itory on 18 March 2007. In addition, extra searches were performed using only the
complete genomes of B. longum NCC2705 and Bifidobacterium adolescentis ATCC
15703 (Gifu University, Life Science Research Center, Japan). For the nucleotide
searches, all matches with the genome sequences were analyzed for annotated
features using the protein and RNA annotation files of the genomes.
FIG. 2. Growth (OD600) (A) and pH (B) of B. longum on glucose (}), GOS (f), and no carbon source (). An arrow indicates the harvest
point for RNA isolation. Error bars indicate standard deviations.
FIG. 3. Hybridization scheme for the different growth media
tested. The arrowheads correspond to the Cy5-labeled samples, and
the dots at the ends of the arrows correspond to the Cy3-labeled
samples.
FIG. 4. Venn diagram showing the number of differential and com-
monly hybridized clones in human breast milk (BM) compared to
formula milk (FM) and human milk compared to glucose medium
(Gl).
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RESULTS AND DISCUSSION
Growth and gene expression of B. longum in human and
formula milks and glucose medium. To identify the different
effects of human and formula milk on the metabolism of B.
longum, the transcriptomes obtained after growth in the milks
were compared to the transcriptome obtained during growth in
glucose medium. B. longum displayed a lower growth rate in
the human milk than in the formula milk and glucose medium
(Fig. 1), possibly due to the presence of antimicrobial sub-
stances (39). The growth rate appeared highest in the formula
milk, and there was a corresponding rapid drop in the pH. The
pH profiles for human milk and glucose medium were compa-
rable. Mid-exponential phase for all media was reached after
approximately 4 h, and at this time samples were taken for
TABLE 1. B. longum genes upregulated in human milk compared to formula milk and glucose medium
Locus tag(s)a Function KEGG functioncodeb
Fold change
(log 2 ratio)c
Glucose Formula
BL1638 Solute binding protein of ABC transporter for sugars MT 5.54 0
DVU1515 Type II DNA modification methyltransferase, putative (Desulfovibrio vulgaris
subsp. vulgaris strain Hildenborough)
FU 5.07 6.46
BL1639 Permease of ABC transporter for sugars MT 4.52 4.39
BL1642 Putative desulfatase, possibly for mucin FU 4.47 4.56
BL1673–BL1674 Possible lactaldehyde reductase; probable glycosyltransferase C, FU 4.41 4.09
BL0978 -Galactosidase (lacZ) C 4.29 2.40
EF2229 Hypothetical protein (Enterococcus faecalis V583) FU 3.85 
BL1344 N-Acetylglucosamine-6-phosphate deacetylase C 3.26 3.62
BL0919–BL0920 Possible efflux transporter protein FU 3.22 3.53
BL1343 Glucosamine-6-phosphate deaminase C 3.13 4.0
BL1673 Possible lactaldehyde reductase C 2.98 
BL0454–BL0455 Narrowly conserved hypothetical protein; widely conserved hypothetical
membrane protein
FU 2.93 5.06
BL1674 Probable glycosyltransferase C 2.61 
BL1211 Galactose-1-phosphate uridylyltransferase C 2.11 
BL0992 30S ribosomal protein S1 TR 2.09 
BL1411 Cell division protein FtsK PS 1.99 2.04
BL0951–BL0953 Formate acetyltransferase; hypothetical protein; glutamine-dependent
NAD() synthetase
C, FU, NM 1.90 2.27
BL0675 Possible cell surface protein similar to FimA fimbrial subunit of A. naeslundii FU 1.73 1.78
BL0676 Sortase-like protein similar to fimbria-associated protein of A. naeslundii FU 1.69 1.71
BL1164 Probable solute binding protein of ABC transporter system for sugars MT 1.44 0
BL0949–BL0950 Narrowly conserved hypothetical protein; pyruvate formate-lyase 1 activating
enzyme
FU, EM 1.40 
BL1402–BL1403 Response regulator of two-component system; atypical histidine kinase
sensor of two-component system
EP 1.24 
BL1589 30S ribosomal protein S17 TR 1.22 
BL0197–BL0198 Possible ATP binding protein of ABC transporter; hypothetical membrane
protein with unknown function
FU 1.17 
BL1164–BL1165 Probable solute binding protein of ABC transporter system for sugars;
probable solute binding protein of ABC transporter system for sugars
MT 1.11 0
BL0716 Transketolase C 0.99 
BL0715 Transaldolase C 0.81 
BL0157 Narrowly conserved hypothetical protein FU 0.56 
BL0671–BL0672 Ribonucleotide-diphosphate reductase beta subunit; probable
glycosyltransferase
N, FU 0.47 1.73
BL0433–BL0434 Protein PII-uridylyltransferase; nitrogen regulatory protein N-II EP, NM, EM 0.36 2.34
BL1545–BL1546 30S ribosomal protein S15; a polyribonucleotide nucleotidyl-transferase TR, N 0.22 
BL0976 Galactoside symporter (lacS) MT 0.20 
BL0742 Probable helicase RR 0.16 
BL0284 Fem AB-like protein for formation of peptidoglycan CP  0
BL0529 Probable -1,4-glucosidase C  0
BL0544 -L-Arabinosidase C  0
BL0872 Possible ABC transporter component MT  0
BL0966 Phosphoglycerate mutase C  0
BL0993–BL0994 Methylenetetrahydrofolate dehydrogenase (NADP), solute binding protein
(zinc/manganese) of ABC transporter system
CV, MT  0
BL1169–BL1170 Probable permease of ABC transporter system for sugars MT  0
BL1731–BL1732 Hypothetical protein; methionine aminopeptidase NM  0
a Genes that were significantly upregulated in human milk compared to both glucose medium and formula milk are in boldface.
b KEGG, Kyoto Encyclopedia of Genes and Genomes. Function codes are as follows: C, carbohydrate metabolism; CV, metabolism of cofactors and vitamins; EM,
energy metabolism; EP, environmental information processing; FU, function unknown; MT, membrane transport; N, nucleotide metabolism; NM, nitrogen metabolism;
PS, cellular processes and signaling; RR, replication and repair; TR, translation.
c 0, expressed but not upregulated; , no significant signal detected.
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RNA isolation and subsequently hybridized to clone-based B.
longum microarrays. In order to identify genes that were spe-
cifically induced upon growth under the different conditions,
the clones with significant hybridization signals due to the
different conditions were grouped, and the numbers of each
group are presented as Venn diagrams (Fig. 4). Growth in
human or formula milks resulted in the expression of B. lon-
gum RNA that shared significant hybridization signals with 409
clones. In the sections below, the genes expressed under the
various conditions are described and compared.
Analysis of the microarrays identified 92 clones that showed
significant hybridization signals with cDNA from RNA sam-
ples isolated from human milk compared to formula and glu-
cose medium; 35 of these clones were sequenced, and the
genes were tentatively identified (Table 1). Of these clones, 21
contained genes predicted to be involved in carbohydrate me-
tabolism and sugar membrane transport, and 6 could code for
general cellular processes; the function of 8 other clones was
unknown.
Genes expressed during growth in both human and formula
milks versus semisynthetic medium containing glucose. Hy-
bridization patterns of both human and formula milk were
compared to glucose medium to identify specific milk-induced
gene expression of B. longum.
(i) Carbohydrate metabolism. Despite the addition of oli-
gosaccharides to the formula milk, there were only a few genes
implicated in carbohydrate metabolism that were similarly up-
regulated during growth in both formula and human milk.
These included two putative glycosyl hydrolases (BL0529 and
BL0544) (Tables 1 and 2) and an ATP-binding cassette (ABC)-
type transporter (BL1164-BL1165), which were reported to be
induced by FOS and lactose in semisynthetic medium (33), and
a solute-binding protein of ABC transporter for sugars
(BL1638) (Table 1).
(ii) Nitrogen metabolism. Genes predicted to encode pro-
tein PII-uridylyltransferase (glnD) and a nitrogen regulatory
protein N-II (glnB) (BL0433 and BL0434, respectively) were
upregulated during growth of B. longum in human milk com-
pared to glucose medium and to an even greater degree in
formula milk. These genes were shown to be involved in reg-
ulation of glutamine synthetase activity in Escherichia coli that
plays an essential role in the metabolism of nitrogen by cata-
lyzing the condensation of glutamate and ammonia to form
glutamine (32). The B. longum genome contains all homologs
needed for biosynthesis of pyrimidine and purine nucleotides
from glutamine (38). Glutamate synthetase is regulated through a
complex series of events in E. coli and many bacteria in response
to a low ammonia concentration in the environment (31). In-
terestingly, ammonia may be liberated by glucosamine-6-P
isomerase (BL1343), and the predicted gene for this enzyme
(see below) was significantly upregulated in human milk. A
clone encoding a hypothetical protein and a putative methio-
nine aminopeptidase (BL1731 and BL1732, respectively) could
indicate removal of the N-terminal methionine from nascent
proteins; this clone was upregulated in both milks. Two of the
other putative specific transport systems for peptides in the B.
longum DJ010A (26) were not detected, either due to low
signals or possibly due to the absence of these genes in the
clone library. The nitrogen content in formula milk originates
mainly from proteins and oligopeptides. The nitrogen regula-
tory proteins as well as genes involved in amino acid metabo-
lism indicate assimilation of nitrogen by B. longum via peptide
hydrolysis. Another upregulated gene shared by both milks was
a putative ABC transporter for zinc and manganese (BL0993
and BL0994).
(iii) Colonization factors. Two genes for cell surface pro-
teins with high similarity to the type 2 glycoprotein-binding
FimA fimbrial subunit and sortase-like fimbria-associated pro-
TABLE 2. B. longum genes highly upregulated in formula compared to human milk
Locus tag(s)a Function KEGG functioncodeb
Fold change
(log 2 ratio)
BL0012–BL0013 Hypothetical protein weakly similar to putative transcriptional regulator from
Streptomyces; proline/betaine transporter
FU 4.30
BL1647 Hypothetical protein FU 4.23
BL1534 Putative biotin biosynthesis protein BioY FU 3.45
BL0841–BL0842 Hypothetical protein; widely conserved hypothetical transmembrane protein with duf013 FU 3.01
BL1537 Fatty acid synthetase (Fas) LM 2.86
BL1775 Fragment of -galactosidase C 2.83
BL1148 Deoxyguanosinetriphosphate triphosphohydrolase-like protein N 2.63
BL1114–BL1115 Hypothetical protein in ImpB/MucB/SamB family of UV repair proteins; S-adenosyl-L-
homocysteine hydrolase
RR, A 2.45
BL0841–BL0842 Hypothetical protein; widely conserved hypothetical transmembrane protein with duf013 FU 2.45
BL0433–BL0435 Protein PII-uridylyltransferase; nitrogen regulatory protein N-II; possible ammonium
ion transporter
NM, MT 2.34
BL0613 Probable integral membrane transporter MT 1.96
BL0675 Possible cell surface protein similar to FimA fimbrial subunit of A. naeslundii FU 1.78
BL0671–BL0672 Ribonucleotide-diphosphate reductase  subunit; probable glycosyltransferase N, FU 1.73
BL0676 Sortase-like protein similar to fimbria-associated protein of A. naeslundii FU 1.71
BL0433–BL0434 Protein PII-uridylyltransferase; nitrogen regulatory protein N-II NM 1.63
BL1647–BL1648 Hypothetical protein FU 1.60
BL0604 Phosphoenolpyruvate carboxylase C, EM 0.69
a Genes that were also induced in human milk compared to glucose are shown in boldface.
b A, amino acid metabolism; LM, lipid metabolism. For other abbreviations, see Table 1, footnote b.
4690 GONZA´LEZ ET AL. APPL. ENVIRON. MICROBIOL.
tein of the oral inhabitant Actinomyces naeslundii, in clones
BL0675 and BL0676, respectively (Tables 1 and 2), were highly
upregulated during growth of B. longum in human milk and
even more in formula milk (Table 2). These proteins are in-
volved in the adhesion of A. naeslundii to microbial oral bio-
films and interaction with epithelial surfaces (29, 32). The
putative FimA fimbrial subunit clone BL0675 contained other
motifs: a putative immunoglobulin domain found in other cell-
surface proteins and a Cna protein B-type domain found in the
Staphylococcus aureus collagen-binding surface protein, which
forms a repetitive -sandwich structure that presents the
ligand-binding domain away from the bacterial cell surface.
The putative sortase-like fimbria-associated surface protein
BL0676 contained the sortase LPXTG motif, which can func-
tion as an anchor on the cell wall. There is some tentative
evidence that bifidobacteria have fimbria-like structures (38);
however, further characterization is required to determine if
they contribute to attachment or retention in the human in-
testine.
Genes upregulated specifically during growth in human
milk. Complex neutral oligosaccharides have been identified as
the most likely prebiotic factors in human milk that stimulate
the growth of bifidobacteria in the infant gut. This was sup-
ported by the high percentage of upregulated genes with pre-
dicted functions in the transport and metabolism of oligosac-
charides in human compared to formula milk (Table 1).
Significantly upregulated genes included those for putative
N-acetylglucosamine-6-P deacetylase (BL1344) that catalyzes
the deacetylation of N-acetyl-D-glucosamine 6-P and glucosa-
mine-6-phosphate isomerase 1 (BL1343), which converts
D-glucosamine-6-P to D-fructose-6-P and ammonia. N-Acetyl-
glucosamine-containing oligosaccharides are regarded as the
most bifidogenic oligosaccharides in human milk (24). Conse-
quently B. longum would be able to use the N-acetylglucos-
amine-6-P in the human milk as a source of carbon and
nitrogen. Other significant genes involved in carbohydrate
metabolism upregulated specifically in human milk included a
putative desulfatase (BL1642) and sugar permease subunit
(BL1639) (Table 1). The latter forms part of a novel putative
operon for metabolism of mucin sugars and human milk oligo-
saccharides in B. longum JCM1217. The complete operon
encodes an ABC-type sugar transporter, lactose-N-biose phos-
phorylase, mucin desulfatase, galactose-1-phosphate uridylyl-
transferase, and UDP-glucose 4-epimerase. It has been spec-
ulated that this operon plays a critical role in the bifidogenic
effect of human milk as the lacto-N-biose structure appears to
be unique to human milk oligosaccharides (20); moreover,
intestinal colonization by bifidobacteria would be enhanced by
metabolism of mucin sugars. The putative (galacto)oligosac-
charide transporter genes (BL1638 and BL1639) were previ-
ously found to be induced in vitro by FOS and expressed but
not induced by lactose, raffinose, and maltose (33). Another
gene involved in galactose metabolism, a galactose-1-phos-
phate uridylyltransferase gene (BL1211), was also specifically
upregulated in breast milk.
As expected, since lactose is the predominant sugar in milk,
a putative galactoside transporter gene for lactose transport,
lacS (in clone BL0976), was upregulated in human milk al-
though rather surprisingly not in formula milk. In fact, the
amount of lactose reaching the newborn colon from breast as
well as formula milk is low since it is absorbed in the ileum
(11). However, the expression of lacS in B. longum NCC2705
was shown to be induced by several carbohydrates besides
lactose including raffinose, maltose, and FOS (33, 34), so per-
haps alternative sugar sources such as oligosaccharides specific
to human milk promoted the upregulation. Significant upregu-
lation of a putative -galactosidase gene (lacZ, or BL0978) was
also detected during growth in human milk and again not in
formula milk; lacZ may be involved in hydrolysis of lactose to
glucose and galactose, and/or alternatively in hydrolysis of ter-
minal nonreducing -D-galactose residues in milk oligosaccha-
rides (8). A tentative lactaldehyde reductase (BL1673) gene
that anaerobically reduces L-lactaldehyde (a product of both
the L-fucose and L-rhamnose catabolic pathways to L-1,2-pro-
panediol) was highly upregulated (30) only in human milk. It is
noteworthy that L-fucose can be derived from human milk
oligosaccharides (24) or mucin sugars. Putative genes for trans-
ketolase and transaldolase, involved in the pentose phosphate
pathway (BL0715, BL0716, and BL0966), were upregulated to
a great extent in the human milk compared to glucose medium.
The pentose phosphate pathway, besides energy metabolism, is
used for reducing agents, nucleotide formation, and reducing
equivalents for synthetic purposes (41), suggesting an en-
hanced requirement for the latter in human milk. The bi-
fidobacterial transaldolase protein was previously identified in
vivo in fresh infant feces as well as in batch cultures in MRS
medium via a proteomics approach (21). This supports the
assumption that the genes expressed in these in vitro studies in
milk can also be expected in vivo.
Highly upregulated genes in formula milk versus human
milk. There were 54 genes significantly upregulated in formula
milk compared to human milk (and glucose medium), and the
sequences of 17 clones have been determined (Table 2).
Among the genes tentatively identified were those annotated
for carbohydrate utilization, including a fragment of lacZ and
a glucosyltransferase (BL1775 and BL0672). Overall, the num-
ber of differentially expressed genes involved in carbohydrate
metabolism in formula milk was much lower than the number
upregulated in human milk. One could speculate that this is
due to a lower carbohydrate metabolism by B. longum in for-
mula milk with GOS-lcFOS than in human milk, as the com-
plexity of the carbohydrates in breast milk is much higher and
is likely to induce a more complex carbohydrate metabolism
than the formula milk. However, an insufficient number of
clones were sequenced and identified to confirm this.
A few of the genes were also upregulated during growth of
B. longum in human milk but more strongly in formula milk
(Table 2). Specifically, the putative genes for regulation of
glutamine synthase activity (BL0433 and BL0434) were more
highly upregulated in formula milk than in human milk. The
same was observed for the potential fimbria genes discussed
above. Other formula-specific upregulated genes were pre-
dicted to be involved in transport such as a possible oxalate/
formate transporter (BL0613), lipid metabolism (BL1537), and
several genes of unknown function. A nucleotide hydrolyzing
gene (BL1148) was found to be upregulated, as well as a
ribonucleotide-2P reductase gene (BL0671), possibly due to
the influence of the high level of nucleotides in formula com-
pared to human milk. A putative bioY gene (BL1534) encoding
part of a group of BioMNY proteins, which are considered to
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constitute tripartite biotin ABC-transporters in prokaryotes,
was significantly upregulated in formula milk (17). This might
be due to the presence of a high concentration of biotin in the
formula milk (17 g/liter) compared to the human milk used in
this study; the level in the latter can vary from 5 to 11 g/liter
(4). Enzymes needed for synthesis of biotin appeared to be
missing from the B. longum genome sequence (38).
Growth and transcriptomics of B. longum in GOS medium.
The transcriptome of B. longum growing on GOS medium
compared with glucose medium was studied at mid-exponen-
tial growth (Fig. 2).
B. longum showed a relatively lower specific growth rate on
GOS (  0.24  0.008 h1) than on glucose (  0.27 
0.044 h1) with a concomitant slower production of acids. No
growth was observed when the bacteria were grown on the
semisynthetic medium without a carbon source (Fig. 2). Com-
parison of the transcriptome of B. longum grown in GOS
medium with glucose showed 91 clones with significantly in-
duced signals (Table 3). Sequencing of 36 clones revealed 25
involved in carbohydrate metabolism and transport, 1 in amino
acid biosynthesis, 1 in ribosomal genes, 1 in genetic informa-
tion, 1 in cellular processes, and 17 with unknown functions.
The Venn diagram (Fig. 5) indicates that many more genes are
upregulated with growth in GOS than with growth in glucose,
probably due to the complex nature of GOS. The degradation
of GOS requires a wide range of enzymes and transporters for
uptake into the cell, and these are discussed below.
Genes specifically upregulated in GOS medium. In compar-
ison to glucose medium and the human and formula milks,
putative genes unique to GOS included -galactosidase I
(BL0259) and genes coding for an ABC sugar permease trans-
porter (BL0260 and BL0261) within the same gene cluster.
These proteins were reported to be similar to the predicted
lactose ABC permease of Streptomyces coelicolor and were
shown to be expressed by growth on lactose, raffinose, maltose,
and FOS by B. longum NCC2705 (33). Another sugar per-
TABLE 3. B. longum induced genes by growth on GOS compared to glucose medium
Locus tag(s)a Function KEGG functioncoded
Fold change
(log 2 ratio)
BL0978 -Galactosidase (lacZ) C 3.9
BL1673–BL1674 Possible lactaldehyde reductase; probable glycosyltransferase C, FU 3.83
BL1164b Probable solute binding protein of ABC transporter system for sugars MT 3.75
BL1164–BL1165b Probable solute binding protein of ABC transporter system for sugars; probable solute
binding protein of ABC transporter system for sugars
MT 3.43
BL1673 Possible lactaldehyde reductase C 3.38
BL1402–BL1403 Response regulator of two-component system; atypical histidine kinase sensor of two-
component system
FU 3.12
BL0157 Narrowly conserved hypothetical protein FU 3.09
BL0157–BL0158 Narrowly conserved hypothetical protein; very narrowly conserved hypothetical protein FU 2.96
BL0919 Possible efflux transporter protein FU 2.78
BL0976 Galactoside symporter (lacS) C 2.66
BL0949–BL0950 Narrowly conserved hypothetical protein; pflA pyruvate formate-lyase 1 activating
enzyme
FU, PyM 2.46
BL0260–BL0261 Sugar transport system permease protein; sugar transport system permease protein MT 2.42
BL0950–BL0951 Pyruvate formate-lyase 1 activating enzyme, formate acetyltransferase PyM 2.24
BL0259 -Galactosidase I C 2.20
BL0951–BL0953 Formate acetyltransferase (pfl); hypothetical protein; glutamine-dependent NAD()
synthetase (nadE)
PyM, FU, CV 2.17
BL1638 Solute binding protein of ABC transporter for sugars MT 2.13
BL1523 Sugar permease of ABC transporter system MT 2.01
DVU1515 Putative type II DNA modification methyltransferase (Desulfovibrio vulgaris subsp.
vulgaris strain Hildenborough)
FU 1.77
BL0157 Narrowly conserved HP FU 1.58
BL1639 Permease of ABC transporter for sugars MT 1.57
BL1674 Probable glycosyltransferase FU 1.49
BL0978 b -Galactosidase (lacZ) C 1.45
BL0699 Hypothetical myosin-like protein with unknown function FU 1.39
BL0454–BL0455 Narrowly conserved hypothetical protein; widely conserved hypothetical membrane
protein
FU 1.30
BL1211 Galactose-1-phosphate uridylyltransferase C 1.24
BL1411 Cell division protein FtsK PS 1.17
BL1571–BL1573 50S ribosomal protein L13; rpsI 30S ribosomal protein S9; probable glycogen operon
protein GlgX
R, C 1.05
BL1098 Elongation factor G GI 1.04
BL1646–BL1647 Possible histidine kinase sensor of two component system; hypothetical protein FU 0.92
BL1647–BL1648b Hypothetical protein FU 0.89
BL1396–BL1397 Probable cation-transporting ATPase; aconitate hydratase FU, C 0.69
BL1731–BL1732c Hypothetical protein; methionine aminopeptidase (map) PM 0.57
a Genes in boldface are also induced in human milk compared to glucose; underlined genes are induced in human milk compared to formula milk.
b Induced in formula compared to human milk.
c Expressed but not induced under all other conditions.
d GI, genetic information processing; PM, protein metabolism, PyM, pyruvate metabolism. For other abbreviations, see Table 1, footnote b.
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mease transport system (BL1523) was also specifically induced
by GOS; the latter was previously shown to be induced by
raffinose in vitro (33) and also in this study (data not shown).
Shared upregulated genes in GOS medium with human or
formula milks. There was substantial overlap in the upregu-
lated carbohydrate utilization genes between the GOS medium
and human milk. Other putative genes for -galactosidase
(BL0978), galactoside transport (BL0976), galactose-1-phosphate
uridylyltransferase (BL1211), glycosyltransferase (BL1674), and
possible lactaldehyde reductase (BL1673) were detected and
were also upregulated in human milk (Tables 1 and 3), indi-
cating specifically induced carbohydrate metabolism. Genes
BL1638 and BL1639, which form part of a predicted trans-
porter in a novel gene cluster for metabolism of mucin sugars
and human milk oligosaccharides as described above (Table 3)
(20), and other genes for transport of sugars (BL1164-BL1165)
were significantly upregulated in GOS medium and human and
formula milks compared to glucose medium.
Conclusions. The gene expression of B. longum, a common
intestinal bacterium, was studied to gain insight into the effects
of human breast milk versus formula milk on its functionality
and associated health effects within the human intestine. Tran-
scriptomes for human milk and GOS medium showed substan-
tial overlap in the upregulation of carbohydrate utilization
genes, presumably due to the large amount of GOS and ga-
lactose in these substrates. In contrast, there were fewer genes
for sugar utilization shared between the human and formula
milks among the clones sequenced despite the GOS-lcFOS
(1:9) oligosaccharides present in the formula milk. Moreover,
genes involved in carbohydrate metabolism formed the most
dominant group specifically upregulated in breast milk. The
latter included putative genes for N-acetylglucosamine degra-
dation (BL1642) and metabolism of mucin and human milk
oligosaccharides via the novel galactose/lacto-N-biose operon
with associated sugar transporters (BL1638 and BL1639), of
which only the transporters were also induced by GOS and
formula milk with GOS-lcFOS. This supports the reported
findings that the bifidogenic effect of human milk is to a great
extent based on its unique and complex oligosaccharides. It
was interesting that the putative genes for cell surface type 2
glycoprotein-binding fimbriae that are implicated in attach-
ment and colonization in the intestine appeared to be upregu-
lated only in the milks. Importantly, the present study gener-
ates leads for further investigation of genes involved in the
metabolism and colonization of B. longum in the infant human
intestine.
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